| Product Code: ETC9690107 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Nephrology Drugs Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Nephrology Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand Nephrology Drugs Market - Industry Life Cycle |
3.4 Thailand Nephrology Drugs Market - Porter's Five Forces |
3.5 Thailand Nephrology Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Thailand Nephrology Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Thailand Nephrology Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Thailand Nephrology Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic kidney diseases in Thailand |
4.2.2 Growing aging population in Thailand leading to higher demand for nephrology drugs |
4.2.3 Technological advancements in the field of nephrology drugs leading to better treatment options |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in Thailand |
4.3.2 High cost associated with nephrology drugs impacting affordability for patients |
4.3.3 Limited awareness about nephrology diseases and treatments among the general population in Thailand |
5 Thailand Nephrology Drugs Market Trends |
6 Thailand Nephrology Drugs Market, By Types |
6.1 Thailand Nephrology Drugs Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Thailand Nephrology Drugs Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Thailand Nephrology Drugs Market Revenues & Volume, By ACE Inhibitors, 2021- 2031F |
6.1.4 Thailand Nephrology Drugs Market Revenues & Volume, By Calcium Channel Blocker, 2021- 2031F |
6.1.5 Thailand Nephrology Drugs Market Revenues & Volume, By Beta Blockers, 2021- 2031F |
6.1.6 Thailand Nephrology Drugs Market Revenues & Volume, By Diuretics, 2021- 2031F |
6.1.7 Thailand Nephrology Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Thailand Nephrology Drugs Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Thailand Nephrology Drugs Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 Thailand Nephrology Drugs Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.2.4 Thailand Nephrology Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Thailand Nephrology Drugs Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Thailand Nephrology Drugs Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.3.3 Thailand Nephrology Drugs Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.3.4 Thailand Nephrology Drugs Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Thailand Nephrology Drugs Market Import-Export Trade Statistics |
7.1 Thailand Nephrology Drugs Market Export to Major Countries |
7.2 Thailand Nephrology Drugs Market Imports from Major Countries |
8 Thailand Nephrology Drugs Market Key Performance Indicators |
8.1 Number of nephrology drug prescriptions by healthcare providers |
8.2 Percentage of patients with chronic kidney diseases receiving appropriate nephrology drug treatments |
8.3 Adoption rate of new nephrology drugs in the market |
9 Thailand Nephrology Drugs Market - Opportunity Assessment |
9.1 Thailand Nephrology Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Thailand Nephrology Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Thailand Nephrology Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Thailand Nephrology Drugs Market - Competitive Landscape |
10.1 Thailand Nephrology Drugs Market Revenue Share, By Companies, 2024 |
10.2 Thailand Nephrology Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here